Cargando…

The Role of Physicians’ Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus

Background and Objectives: The constantly increasing prevalence of type 2 diabetes mellitus (T2DM) and the advent of new treatment options have made management of T2DM patients more demanding. We aimed to (a) estimate the familiarity of general practitioners with novel T2DM treatment options, (b) de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janež, Andrej, Ješe, Rok, Haluzík, Martin, Rizzo, Manfredi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413967/ https://www.ncbi.nlm.nih.gov/pubmed/36013528 http://dx.doi.org/10.3390/medicina58081061

Ejemplares similares

Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review
por: Jensterle, Mojca, et al.
Publicado: (2022)

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2023)

Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly
por: Herman, Rok, et al.
Publicado: (2022)

Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues
por: Rizvi, Ali A., et al.
Publicado: (2021)

Noninsulin pharmacological management of type 1 diabetes mellitus
por: Garg, Vishvas
Publicado: (2011)

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
por: Popovic, Djordje S., et al.
Publicado: (2021)

Relation of prediabetes and type 2 diabetes mellitus to thyroid cancer
por: Grimmichova, T, et al.
Publicado: (2020)

Glucagon-Like Peptide 1 and Taste Perception: From Molecular Mechanisms to Potential Clinical Implications
por: Jensterle, Mojca, et al.
Publicado: (2021)

Semaglutide in Obesity: Unmet Needs in Men
por: Jensterle, Mojca, et al.
Publicado: (2023)

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
por: Janić, Miodrag, et al.
Publicado: (2022)

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
por: Lunder, Mojca, et al.
Publicado: (2018)

Herbal therapy: A review of emerging pharmacological tools in the management of diabetes mellitus in Africa
por: Kibiti, Cromwell Mwiti, et al.
Publicado: (2015)

The Effect of Additional Treatment with Empagliflozin or Semaglutide on Endothelial Function and Arterial Stiffness in Subjects with Type 1 Diabetes Mellitus—ENDIS Study
por: Navodnik, Maja Preložnik, et al.
Publicado: (2023)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Non-pharmacological Treatment Options in the Management of Diabetes Mellitus
por: Raveendran, Arkiath V, et al.
Publicado: (2018)

Evaluation of the knowledge and practice of family physicians in the management of diabetes mellitus type 2 in Iran
por: Haghighinejad, Hourvash, et al.
Publicado: (2023)

Pharmacological approaches to the prevention of type 2 diabetes mellitus
por: Majety, Priyanka, et al.
Publicado: (2023)

Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options
por: Rizvi, Ali A., et al.
Publicado: (2021)

Prevalence of lean type 2 diabetes mellitus in recently diagnosed type 2 diabetes mellitus patients
por: Chaudhary, Prateek, et al.
Publicado: (2013)

Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment
por: Pivari, Francesca, et al.
Publicado: (2019)

Type 1 diabetes mellitus in Bhutan
por: Wangdi, Tashi
Publicado: (2015)

Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
por: Janež, Andrej, et al.
Publicado: (2020)

A Novel Quantitative Approach to Staging and Assessing Recovery from Type 1 Diabetes Mellitus: The Type 1 Diabetes Mellitus Metabolic Recovery Index
por: Orban, Tihamer, et al.
Publicado: (2020)

Pharmacologic Treatment Strategies in Children with Type 2 Diabetes Mellitus
por: Urakami, Tatsuhiko, et al.
Publicado: (2013)

Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms
por: Naz, Rabia, et al.
Publicado: (2023)

The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
por: Bica, Ioana-Cristina, et al.
Publicado: (2023)

Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries
por: Haluzik, Martin, et al.
Publicado: (2018)

Type 1 diabetes mellitus-common cases
por: Kumar, Surender
Publicado: (2015)

Real life with type 1 diabetes mellitus
por: Yagnik, Deepak
Publicado: (2015)

The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities
por: Steinbrenner, Holger, et al.
Publicado: (2022)

In guidelines physicians trust? Physician perspective on adherence to medical guidelines for type 2 diabetes mellitus
por: Brenner, Sophie, et al.
Publicado: (2020)

Effectiveness and Usability of Digital Tools to Support Dietary Self-Management of Gestational Diabetes Mellitus: A Systematic Review
por: Adesina, Nurudeen, et al.
Publicado: (2021)

From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
por: Pani, Arianna, et al.
Publicado: (2020)

Health-Related Quality of Life Assessment in Older Patients with Type 1 and Type 2 Diabetes
por: Volčanšek, Špela, et al.
Publicado: (2023)

Clinical outcomes of a digitally supported approach for self-management of type 2 diabetes mellitus
por: De Luca, Vincenzo, et al.
Publicado: (2023)

Pharmacological therapies for children with type 2 diabetes mellitus should be individualized
por: Urakami, T, et al.
Publicado: (2013)

Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?
por: Otto-Buczkowska, Ewa, et al.
Publicado: (2017)

Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2
por: Lopes, Graciliana, et al.
Publicado: (2016)

Attitudes and perceptions of people with diabetes mellitus on patient self-management in diabetes mellitus: a Singapore hospital’s perspective
por: Ong, Chong Yau, et al.
Publicado: (2022)

COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia
por: Kramarič, Jelka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ripddsd8ah03qafapvckpe97f5